ribociclib
novartis
['ribo', 'breast', 'ribociclib', 'bcsm']
patients with hr+/her2- advanced breast cancer may reduce ribociclib dose without jeopardizing outcomes #asco22 #bcsm #oncology 
Your online destination for Oncology Nursing news, clinical insights, and resources.